Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?

Pilkington, S M; Watson, R E B

Pilkington, S M; Watson, R E B.

Pilkington SM; Centre for Dermatology Research, School of Biological Sciences, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester, UK.
Watson REB; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Br J Dermatol ; 185(6): 1090-1091, 2021 12.

Article in English | MEDLINE | ID: covidwho-1506622

Subject(s)

COVID-19; Chilblains; Antiviral Agents; Chilblains/diagnosis; Humans; Interferons; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Chilblains / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Br J Dermatol Year: 2021 Document Type: Article Affiliation country: Bjd.20784

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google